Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Galderma S.A.
Since Palforzia likely will be the only peanut allergy drug on market for some time, Nestle announces it will pay about $2.6bn to acquire the 80% of Aimmune it doesn’t own.
CEO Todd Zavodnick said the non-steroidal topical cream is poised to become a blockbuster brand.
UK anesthesia products manufacturer Penlon has received UK regulatory approval for a new ventilator, having taken up the government’s Ventilator Challenge in response to the COVID-19 pandemic.
Smiths Medical is increasing paraPAC ventilator production from hundreds to thousands a month to fulfill 10,000 units as part of the Ventilator Challenge UK consortium.
- OTC, Consumer
- Other Names / Subsidiaries
- CollaGenex Pharmaceuticals, Inc., Nestle S.A.
- Nestle Skin Health S.A.
- Spirig Pharma AG